Skip to main content
SpringerLink
Log in

Inhaled, Nebulised and Oral Bronchodilators in Reflux Disease

  • Chapter
  • First Online:
Reflux Aspiration and Lung Disease

Abstract

Please check the hierarchy of the section headings and confirm if correct.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Amarasiri LD, Pathmeswaran A, de Silva HJ, Ranasinha CD. Prevalence of gastro-oesophageal reflux disease symptoms and reflux-associated respiratory symptoms in asthma. BMC Pulm Med. 2010;10:49.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Kim J, Lee JH, Kim Y, Kim K, Oh YM, Yoo KH, Rhee CK, Yoon HK, Kim YS, Park YB, Lee SW, Lee SD. Association between chronic obstructive pulmonary disease and gastroesophageal reflux disease: a national cross-sectional cohort study. BMC Pulm Med. 2013;13:51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Canning BJ, Mazzone SB. Reflex mechanisms in gastroesophageal reflux disease and asthma. Am J Med. 2003;115(Suppl 3A):45S–8S.

    Article  PubMed  Google Scholar 

  4. Hurst JR, Vestbo J, Anzueto A, Locantore N, Mullerova H, Tal-Singer R, Miller B, Lomas DA, Agusti A, Macnee W, Calverley P, Rennard S, Wouters EF, Wedzicha JA. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363:1128–38.

    Article  CAS  PubMed  Google Scholar 

  5. Rascon-Aguilar IE, Pamer M, Wludyka P, Cury J, Coultas D, Lambiase LR, Nahman NS, Vega KJ. Role of gastroesophageal reflux symptoms in exacerbations of COPD. Chest. 2006;130:1096–101.

    Article  PubMed  Google Scholar 

  6. Terada K, Muro S, Sato S, Ohara T, Haruna A, Marumo S, Kinose D, Ogawa E, Hoshino Y, Niimi A, Terada T, Mishima M. Impact of gastro-oesophageal reflux disease symptoms on COPD exacerbation. Thorax. 2008;63:951–5.

    Article  CAS  PubMed  Google Scholar 

  7. Kiljander TO, Laitinen JO. The prevalence of gastroesophageal reflux disease in adult asthmatics. Chest. 2004;126:1490–4.

    Article  PubMed  Google Scholar 

  8. Leggett JJ, Johnston BT, Mills M, Gamble J, Heaney LG. Prevalence of gastroesophageal reflux in difficult asthma: relationship to asthma outcome. Chest. 2005;127:1227–31.

    PubMed  Google Scholar 

  9. Field SK, Underwood M, Brant R, Cowie RL. Prevalence of gastroesophageal reflux symptoms in asthma. Chest. 1996;109:316–22.

    Article  CAS  PubMed  Google Scholar 

  10. Sontag SJ, O’Connell S, Khandelwal S, Miller T, Nemchausky B, Schnell TG, Serlovsky R. Most asthmatics have gastroesophageal reflux with or without bronchodilator therapy. Gastroenterology. 1990;99:613–20.

    Article  CAS  PubMed  Google Scholar 

  11. Dent J, El-Serag HB, Wallander MA, Johansson S. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2005;54:710–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Kempainen RR, Savik K, Whelan TP, Dunitz JM, Herrington CS, Billings JL. High prevalence of proximal and distal gastroesophageal reflux disease in advanced COPD. Chest. 2007;131:1666–71.

    Article  PubMed  Google Scholar 

  13. Casanova C, Baudet JS, del Valle Velasco M, Martin JM, Aguirre-Jaime A, de Torres JP, Celli BR. Increased gastro-oesophageal reflux disease in patients with severe COPD. Eur Respir J. 2004;23:841–5.

    Article  CAS  PubMed  Google Scholar 

  14. Delaney BC. Review article: prevalence and epidemiology of gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2004;20(Suppl 8):2–4.

    Article  PubMed  Google Scholar 

  15. Global Initiative for Asthma. Global strategy for asthma management and prevention [updated 2015]. 2015.

    Google Scholar 

  16. Dimarino AJ Jr, Cohen S. Effect of an oral beta2-adrenergic agonist on lower esophageal sphincter pressure in normals and in patients with achalasia. Dig Dis Sci. 1982;27:1063–6.

    Article  PubMed  Google Scholar 

  17. Schindlbeck NE, Heinrich C, Huber RM, Muller-Lissner SA. Effects of albuterol (salbutamol) on esophageal motility and gastroesophageal reflux in healthy volunteers. JAMA. 1988;260:3156–8.

    Article  CAS  PubMed  Google Scholar 

  18. Crowell MD, Zayat EN, Lacy BE, Schettler-Duncan A, Liu MC. The effects of an inhaled beta(2)-adrenergic agonist on lower esophageal function: a dose-response study. Chest. 2001;120:1184–9.

    Article  CAS  PubMed  Google Scholar 

  19. Mansfield LE, Stein MR. Gastroesophageal reflux and asthma: a possible reflex mechanism. Ann Allergy. 1978;41:224–6.

    PubMed  CAS  Google Scholar 

  20. Schan CA, Harding SM, Haile JM, Bradley LA, Richter JE. Gastroesophageal reflux-induced bronchoconstriction. An intraesophageal acid infusion study using state-of-the-art technology. Chest. 1994;106:731–7.

    Article  CAS  PubMed  Google Scholar 

  21. Fouad YM, Katz PO, Hatlebakk JG, Castell DO. Ineffective esophageal motility: the most common motility abnormality in patients with GERD-associated respiratory symptoms. Am J Gastroenterol. 1999;94:1464–7.

    Article  CAS  PubMed  Google Scholar 

  22. Michoud MC, Leduc T, Proulx F, Perreault S, DU Souich P, Duranceau A, Amyot R. Effect of salbutamol on gastroesophageal reflux in healthy volunteers and patients with asthma. J Allergy Clin Immunol. 1991;87:762–7.

    Article  CAS  PubMed  Google Scholar 

  23. Lacy BE, Mathis C, DesBiens J, Liu MC. The effects of nebulized albuterol on esophageal function in asthmatic patients. Dig Dis Sci. 2008;53:2627–33.

    Article  CAS  PubMed  Google Scholar 

  24. Johannesson N, Andersson KE, Joelsson B, Persson CG. Relaxation of lower esophageal sphincter and stimulation of gastric secretion and diuresis by antiasthmatic xanthines. Role of adenosine antagonism. Am Rev Respir Dis. 1985;131:26–30.

    PubMed  CAS  Google Scholar 

  25. Stein MR, Towner TG, Weber RW, Mansfield LE, Jacobson KW, McDonnell JT, Nelson HS. The effect of theophylline on the lower esophageal sphincter pressure. Ann Allergy. 1980;45:238–41.

    PubMed  CAS  Google Scholar 

  26. Barnette MS, Barone FC, Fowler PJ, Grous M, Price WJ, Ormsbee HS. Human lower oesophageal sphincter relaxation is associated with raised cyclic nucleotide content. Gut. 1991;32:4–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Osinski MA, Bass P, Gaumnitz EA. Effects of selective phosphodiesterase inhibitors on the opossum lower esophageal sphincter. Gastroenterology. 1998;114:A816.

    Article  Google Scholar 

  28. Park H, Clark E, Conklin JL. Effects of phosphodiesterase inhibitors on oesophageal neuromuscular functions. Neurogastroenterol Motil. 2003;15:625–33.

    Article  CAS  PubMed  Google Scholar 

  29. Hubert D, Gaudric M, Guerre J, Lockhart A, Marsac J. Effect of theophylline on gastroesophageal reflux in patients with asthma. J Allergy Clin Immunol. 1988;81:1168–74.

    Article  CAS  PubMed  Google Scholar 

  30. Ekstrom T, Tibbling L. Influence of theophylline on gastro-oesophageal reflux and asthma. Eur J Clin Pharmacol. 1988;35:353–6.

    Article  CAS  PubMed  Google Scholar 

  31. Ekstrom TK, Tibbling LI. Can mild bronchospasm reduce gastroesophageal reflux? Am Rev Respir Dis. 1989;139:52–5.

    Article  CAS  PubMed  Google Scholar 

  32. Ruzkowski CJ, Sanowski RA, Austin J, Rohwedder JJ, Waring JP. The effects of inhaled albuterol and oral theophylline on gastroesophageal reflux in patients with gastroesophageal reflux disease and obstructive lung disease. Arch Intern Med. 1992;152:783–5.

    Article  CAS  PubMed  Google Scholar 

  33. Rao SS, Mudipalli RS, Remes-Troche JM, Utech CL, Zimmerman B. Theophylline improves esophageal chest pain—a randomized, placebo-controlled study. Am J Gastroenterol. 2007;102:930–8.

    Article  CAS  PubMed  Google Scholar 

  34. Herve P, Denjean A, Jian R, Simonneau G, Duroux P. Intraesophageal perfusion of acid increases the bronchomotor response to methacholine and to isocapnic hyperventilation in asthmatic subjects. Am Rev Respir Dis. 1986;134:986–9.

    Article  CAS  PubMed  Google Scholar 

  35. Daoui S, D’Agostino B, Gallelli L, Alt XE, Rossi F, Advenier C. Tachykinins and airway microvascular leakage induced by HCl intra-oesophageal instillation. Eur Respir J. 2002;20:268–73.

    Article  CAS  PubMed  Google Scholar 

  36. Hamamoto J, Kohrogi H, Kawano O, Iwagoe H, Fujii K, Hirata N, Ando M. Esophageal stimulation by hydrochloric acid causes neurogenic inflammation in the airways in guinea pigs. J Appl Physiol. 1997;82:738–45.

    Article  CAS  PubMed  Google Scholar 

  37. Harding SM, Guzzo MR, Maples RV, Alexander RW, Richter JE. Gastroesophageal reflux induced bronchoconstriction: vagolytic doses of atropine diminish airway responses to esophageal acid infusion [Abstract]. Am J Respir Crit Care Med. 1995;151:A589.

    Google Scholar 

  38. Harding SM, Schan CA, Guzzo MR, Alexander RW, Bradley LA, Richter JE. Gastroesophageal reflux-induced bronchoconstriction. Is microaspiration a factor? Chest. 1995;108:1220–7.

    Article  CAS  PubMed  Google Scholar 

  39. Cui Y, Devillier P, Kuang X, Wang H, Zhu L, Xu Z, Xia Z, Zemoura L, Advenier C, Chen H. Tiotropium reduction of lung inflammation in a model of chronic gastro-oesophageal reflux. Eur Respir J. 2010;35:1370–6.

    Article  CAS  PubMed  Google Scholar 

  40. Desai M, Weller PH, Spencer DA. Clinical benefit from nebulized human recombinant DNase in Kartagener’s syndrome. Pediatr Pulmonol. 1995;20:307–8.

    Article  CAS  PubMed  Google Scholar 

  41. Hayat JO, Gabieta-Somnez S, Yazaki E, Kang JY, Woodcock A, Dettmar P, Mabary J, Knowles CH, Sifrim D. Pepsin in saliva for the diagnosis of gastro-oesophageal reflux disease. Gut. 2015;64:373–80.

    Article  CAS  PubMed  Google Scholar 

  42. Timms C, Thomas PS, Yates DH. Detection of gastro-oesophageal reflux disease (GORD) in patients with obstructive lung disease using exhaled breath profiling. J Breath Res. 2012;6:016003.

    Article  PubMed  Google Scholar 

Download references

Conflict of Interest

None declared with regards to the chapter.

Declarations

KSB has received honoraria for speaking and financial support to attend meetings from Wyeth, Chiesi, GSK, Teva, Novartis and AstraZeneca. JBM has received honoraria for speaking and financial support to attend meetings/advisory boards from Wyeth, Chiesi, Pfizer, MSD, Boehringer Ingelheim, Teva, Glaxo Smithkline/Allen & Hanburys, Napp, Almirall, AstraZeneca, Trudell Medical International and Novartis.

Author information

Authors and Affiliations

  1. Department of Respiratory Medicine, Queen Alexandra Hospital, Portsmouth, UK

    K. Suresh Babu

  2. Department of Respiratory Medicine, Castle Hill Hospital, Cottingham, UK

    Jaymin B. Morjaria

  3. Department of Academic Respiratory Medicine, Hull York Medical School, University of Hull, Cottingham, UK

    Jaymin B. Morjaria

  4. Department of Respiratory Medicine, Royal Brompton and Harefield NHS Trust, Harefield Hospital, Harefield, UK

    Jaymin B. Morjaria

Authors
  1. K. Suresh Babu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jaymin B. Morjaria
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jaymin B. Morjaria .

Editor information

Editors and Affiliations

  1. University of Hull, Hull York Medical School, Cottingham, East Yorkshire, United Kingdom

    Alyn H. Morice

  2. Castle Hill Hospital, RD Biomed Limited, Cottingham, East Yorkshire, United Kingdom

    Peter W. Dettmar

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Suresh Babu, K., Morjaria, J.B. (2018). Inhaled, Nebulised and Oral Bronchodilators in Reflux Disease. In: Morice, A., Dettmar, P. (eds) Reflux Aspiration and Lung Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-90525-9_26

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-90525-9_26

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-90523-5

  • Online ISBN: 978-3-319-90525-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation